FDA Begins Action to Remove Ingestible Fluoride Prescription Drug Products for Children from the Market

This U.S. Department of Health and Human Services (DHHS) press release announces that the U.S. Food and Drug Administration (FDA) is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market. The FDA set a goal date of October 31 for completing a safety review and public comment period and for taking appropriate action regarding removal of these products from the market. In conjunction with this evaluation, DHHS plans to disseminate best practices for dental hygiene in children that are feasible, effective and do not alter gut health.